Clinical Development Stocks List
Symbol | Grade | Name | % Change | |
---|---|---|---|---|
ONCT | D | Oncternal Therapeutics, Inc. | 1.21 | |
PULM | D | Pulmatrix, Inc. | 1.63 | |
CYTK | D | Cytokinetics, Incorporated | -1.24 | |
AFMD | D | Affimed Therapeutics B.V. | 7.14 | |
EQ | D | Equillium, Inc. | 2.04 | |
RCUS | F | Arcus Biosciences, Inc. | 0.94 | |
MRSN | F | Mersana Therapeutics, Inc. | -2.92 | |
LIXT | F | Lixte Biotechnology Holdings, Inc. | 0.35 | |
ORGS | F | Orgenesis Inc. | 5.95 | |
CPIX | F | Cumberland Pharmaceuticals Inc. | 2.07 |
Related Industries: Biotechnology Diagnostics & Research Drug Manufacturers - Specialty & Generic Information Technology Services Medical Devices
Related Stock Lists:
Medicine
Cancer
Biopharmaceutical
Biotechnology
Monoclonal Antibodies
Immune Checkpoint
Immunology
Immunotherapies
Medicinal Product
Monoclonal Antibody
Sarcoma
Solid Tumors
Treatment Of Cancer
Adenosine
Amyotrophic Lateral Sclerosis
Analgesics
Antibody
Antibody Drug Conjugate
Assay Development Services
Autoimmunity
Symbol | Grade | Name | Weight | |
---|---|---|---|---|
SBIO | D | ALPS Medical Breakthroughs ETF | 1.58 | |
BBC | D | Virtus LifeSci Biotech Clinical Trials ETF | 1.28 | |
BBP | C | BioShares Biotechnology Products Fund | 1.14 | |
XBI | D | SPDR S&P Biotech ETF | 0.73 | |
BTEC | D | Principal Healthcare Innovators Index ETF | 0.5 |
Compare ETFs
Related Industries:
Biotechnology
Diagnostics & Research
Drug Manufacturers - Specialty & Generic
Information Technology Services
Medical Devices
Related Stock Lists:
Biopharmaceutical
Medicine
Autoimmune Disease
Cancer
Drugs
Abdominal Pain
Breast Cancer
Clinical Medicine
Colitis
Crohn's Disease
Immunology
Immunotherapy
Life Sciences
Pharmaceutical
Sarcoma
Treatment Of Breast Cancer
Ulcer
Ulcerative Colitis
Acute Intermittent Porphyria
Acute Myeloid Leukemia
- Clinical Development
Clinical development is the process of developing a new drug, medical device, or diagnostic test from the initial concept to the point of regulatory approval. It involves a series of steps, including preclinical research, clinical trials, regulatory review, and post-marketing surveillance. The goal of clinical development is to demonstrate the safety and efficacy of a product in order to obtain regulatory approval for marketing.
Recent Comments
- ZealousTrout235 on New Scans: Strong, Oversold Stocks and Weak, Overbought Stocks
- TraderMike on Market Recap for Tuesday, May 21, 2024
- CharmingMole371 on Market Recap for Tuesday, May 21, 2024
- TraderMike on IZM
- SuccessfulGerbil321 on IZM
From the Blog
Featured Articles